Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Scientists created MUSIi010-A, a stem cell line from a balding man's scalp, to study hair loss and develop potential treatments.

The research identified various cell types in mouse and human teeth, which could help in developing dental regenerative treatments.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Increasing Rps14 helps grow more inner ear cells and repair hearing cells in baby mice.

Arctiin helps protect hair cells from damage and death caused by oxidative stress.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Cell aging can be both good and bad for tissue repair.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

The circadian clock influences the behavior and regeneration of stem cells in the body.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Stem cell therapy shows promise in improving burn wound healing.